MBMarina O. Babikhina

Marina O. Babikhina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marina O. Babikhina has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ragweed pollen allergens: description and prospects for the development of new highly effective allergy vaccines

    by Anastasiia V. Shatilova, Aizirek A. Asanbaeva, Marina O. Babikhina, Igor P. Shilovskiy, Sergei M. Andreev, Valerii V. Smirnov, Evgeniya V. Nazarova, George B. Pasikhov, Maiia V. Popova, Polina A. Strueva, et al.

    Ragweed pollen allergy is widespread in the South of Russia, the Far East and other regions, where 25 to 40 % of all weeds-allergic patients may be sensitized specifically to ragweed, representing an important public health problem. Drugs of various pharmacological groups used for the treatment of ragweed pollen allergy affect only the symptoms but not the cause of allergy. Existing pathogenetic therapy (allergen-specific immunotherapy with allergy vaccines based on water-salt extracts) requires long courses and can cause significant side effects. The development of more effective allergy vaccines requires the study of the structures of ragweed pollen allergens and the identification of their IgE epitopes. Based on these epitopes, new highly effective allergy vaccines can be developed using recombinant technologies that will lack the disadvantages of water-salt extracts and will possess the ability to enhance the induction of protective IgG. This review is focused on the epidemiology of ragweed pollen allergy, as well as the latest approaches to the analysis of its allergens’ structures and development of allergy vaccines. Presented information is relevant for the development of new promising highly effective allergy vaccines for allergen-specific immunotherapy of ragweed pollen allergy.


  • Open Access

    Novel synthetic antiviral peptides: design, synthesis, physico-chemical analysis and activity

    by A.V. Shatilova, L.V. Saprygina, M.M. Babikhina, E.D. Timotievich, V.I. Kovchina, S.M. Andreev, V.V. Smirnov, D.A. Kudlay, I.P. Shilovskiy, M.R. Khaitov

    Новые синтетические противовирусные пептиды. Проектирование, получение, физико-химический анализ, изучение активности


  • Cationic peptides as promising compounds for the treatment of bacterial complications in atopic dermatitis: Antibacterial activity assessment

    by Anastasia A. Galkina, Darya K. Bolyakina, Anastasia V. Shatilova, Marina O. Babikhina, Alla K. Golomidova, Alexandra A. Nikonova, Sergey M. Andreev, Dmitry A. Kudlay, Nadezda N. Shershakova, Musa R. Khaitov, et al.

    BACKGROUND: The decrease in the effectiveness of antibiotics against the background of resistance of microorganisms aggravates the therapy of atopic dermatitis complicated by bacterial infection and actualizes the development of new antimicrobial agents. AIM: To develop, synthesize, and evaluate the antibacterial activity of cationic peptides and an aqueous solution of fullerene C60 to create drugs based on them that will have a spectrum of biological activity, including anti-inflammatory, antiallergic, and antibacterial activities. MATERIALS AND METHODS: This study analyzed the developed linear and dendrimer cationic peptides, whose structure was confirmed by matrix-assisted laser desorption ionization–time of flight mass spectrometry. An aqueous solution of fullerene C60 was obtained using a uniquely developed and patented technology. Antibacterial activity was assessed by diffusion into agar using disks (screening) and serial dilution, which was used to determine the minimum bactericidal concentration of the studied compounds. RESULTS: Moreover, 42 cationic peptides with various structures were developed and synthesized. The molecular weight of the peptides did not exceed 5,000 Da. They contained 7–25 amino acids with charges from +5 to +16. Screening was carried out through diffusion into agar using disks and revealed 15 peptides that showed activity against Escherichia coli Dh5a. Thus, using the method of counting colonies, the peptides AB-14, AB-17, and AB-18 showed bactericidal activity relative to E. coli Dh5a in concentrations of 0.03, 0.15, and 0.74 mM, respectively, which exceeded that of ampicillin (0.74 mM) several times. Analysis of an aqueous solution of fullerene C60 did not reveal its antibacterial activity. CONCLUSIONS: The antibacterial activity of the resulting peptides makes them promising for the development of antibacterial therapeutic agents.